Heidelberg Pharma AG Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Nov'24
Nov'23
Nov'22
Nov'21
Nov'20
Nov'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-19.00
-20.00
-17.00
-26.00
-18.00
-10.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-11.00
-10.00
9.00
-2.00
0.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-29.00
-33.00
-8.00
-26.00
-17.00
-8.00
Cash Flow from Investing Activities
0.00
5.00
0.00
-1.00
-1.00
0.00
Cash Flow from Financing Activities
16.00
-10.00
84.00
29.00
14.00
0.00
Net Cash Inflow / Outflow
-14.00
-37.00
75.00
1.00
-4.00
-9.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Heidelberg Pharma AG
Figures in Million
consolidated Cash Flow Results
Change(EUR)
Change(%)
Profit Before Tax
-19.381995
26.04
-45.00
-174.43%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-11.989084
-11.135
0.00
-7.67%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-29.587776
21.084
-50.00
-240.33%
Cash Flow from Investing Activities
-0.44913
-1.472
1.00
69.49%
Cash Flow from Financing Activities
16.07732
-33.888
49.00
147.44%
Net Cash Inflow / Outflow
-14.017217
-14.276
0.00
1.81%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.057631
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Nov'24
YoY Growth in year ended Nov 2024 is 12.13% vs -279.87% in Nov 2023
Nov'24
Nov'23
Change(%)
Cash Flow from Operating Activities
-29.59
-33.67
12.13%






